Gene Therapy Latest News | Experimental Gene Therapy Studies

Freeline Raises $120M for Pivotal Trial of FLT180a, a Gene Therapy Candidate for Hemophilia B

10 July 2020

Efficacy of Gene Therapy SB-525 Now at 14 Months in Alta Hemophilia A Trial

19 June 2020

Investigational Gene Therapy Results in Huge Drop in Bleeding Rates and Factor VIII Usage, Updated Data Show

24 June 2020

BioMarin’s Gene Therapy for Hemophilia A Continues to Prevent Bleeds After Four Years, Trial Shows

03 June 2020

FDA Agrees to Phase 1 Trial of ET3, Gene Therapy for Hemophilia A
27 May 2020
3 Hemophilia B Patients Report AMT-060 Gene Therapy Gave Them Normalcy
18 May 2020
Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals
15 May 2020
BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval
13 May 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL